Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Slingluff

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Journal of Surgical Oncology|October 1, 1990
Acral melanoma: a review of 185 patients with identification of prognostic variablesC L Slingluff, R Vollmer, H F Seigler
Journal of Surgical Oncology|November 1, 1988
Stage II malignant melanoma: presentation of a prognostic model and an assessment of specific active immunotherapy in 1,273 patientsC L Slingluff, R Vollmer, H F Seigler
Current Opinion in Oncology|April 6, 2000
Melanoma vaccinesL H Brinckerhoff, L W Thompson, C L Slingluff
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1989
The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigensT L Darrow, C L Slingluff, H F Seigler
Current Opinion in Immunology|October 1, 1994
Direct analysis of tumor-associated peptide antigensC L Slingluff, D F Hunt, V H Engelhard
Surgery|March 1, 1993
Multiple primary melanoma: incidence and risk factors in 283 patientsC L Slingluff, R T Vollmer, H F Seigler
Cancer|July 1, 1988
Autologous lymph node cell-derived tumor-specific cytotoxic T-cells for use in adoptive immunotherapy of human melanomaT L Darrow, C L Slingluff, H F Seigler
Surgery|January 1, 1990
Anorectal melanoma: clinical characteristics and results of surgical management in twenty-four patientsC L Slingluff, R T Vollmer, H F Seigler
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 25, 2016
Statistical controversies in clinical research: early-phase adaptive design for combination immunotherapiesN A Wages, C L Slingluff, G R Petroni
Annals of Surgery|August 1, 1989
Melanoma-specific cytotoxic T cells generated from peripheral blood lymphocytes. Implications of a renewable source of precursors for adoptive cellular immunotherapyC L Slingluff, T L Darrow, H F Seigler
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Journal of Surgical Oncology|October 1, 1990
Acral melanoma: a review of 185 patients with identification of prognostic variablesC L Slingluff, R Vollmer, H F Seigler
Journal of Surgical Oncology|November 1, 1988
Stage II malignant melanoma: presentation of a prognostic model and an assessment of specific active immunotherapy in 1,273 patientsC L Slingluff, R Vollmer, H F Seigler
Current Opinion in Oncology|April 6, 2000
Melanoma vaccinesL H Brinckerhoff, L W Thompson, C L Slingluff
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1989
The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigensT L Darrow, C L Slingluff, H F Seigler
Current Opinion in Immunology|October 1, 1994
Direct analysis of tumor-associated peptide antigensC L Slingluff, D F Hunt, V H Engelhard
Surgery|March 1, 1993
Multiple primary melanoma: incidence and risk factors in 283 patientsC L Slingluff, R T Vollmer, H F Seigler
Cancer|July 1, 1988
Autologous lymph node cell-derived tumor-specific cytotoxic T-cells for use in adoptive immunotherapy of human melanomaT L Darrow, C L Slingluff, H F Seigler
Surgery|January 1, 1990
Anorectal melanoma: clinical characteristics and results of surgical management in twenty-four patientsC L Slingluff, R T Vollmer, H F Seigler
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 25, 2016
Statistical controversies in clinical research: early-phase adaptive design for combination immunotherapiesN A Wages, C L Slingluff, G R Petroni
Annals of Surgery|August 1, 1989
Melanoma-specific cytotoxic T cells generated from peripheral blood lymphocytes. Implications of a renewable source of precursors for adoptive cellular immunotherapyC L Slingluff, T L Darrow, H F Seigler
Pageof 6